Effect of sevelamer on serum phosphorus levels in chronic kidney disease and hemodialysis patients; a systematic review and meta-analysis

Effect of sevelamer on serum phosphorus levels in chronic kidney disease and hemodialysis patients; a systematic review and meta-analysis

Introduction: Hyperphosphatemia is an independent risk factor for mortality in chronic kidney disease (CKD) patients. Objectives: This systematic review and meta-analysis aimed to investigate the effect of Sevelamer on serum phosphorus levels in CKD and hemodialysis patients. Materials and Methods:...

Full description

Bibliographic Details
Main Authors:	Farshad Gharebakhshi, Mohammad Hossein Taklif, Arash Izadpanah Ghahremani, Mohamad Khaledi, Sara Abbasian, Seyedeh Mahsa Shariati Sough, Fatemeh Vashahi Torfi, Hamidreza Khodabandeh, Elnaz Hajian
Format:	Article
Language:	English
Published:	Society of Diabetic Nephropathy Prevention 2024-01-01
Series:	Journal of Nephropathology
Subjects:	sevelamer sevelamer hydrochloride sevelamer carbonate phosphorus chronic kidney disease renal insufficiency hemodialysis renal dialysis extracorporeal dialysis
Online Access:	https://nephropathol.com/PDF/jnp-13-e21463.pdf

Similar Items

Sevelamer-Induced Gastrointestinal Injury Presenting as Gastroenteritis
by: Jared Magee, et al.
Published: (2018-02-01)

Lanthanum carbonate for dialysis patients with hyperphosphataemia resistant to sevelamer: A retrospective cohort study
by: Asrar Khan, et al.
Published: (2016-12-01)

The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
by: Youssef Bennis, et al.
Published: (2019-05-01)

Effect of Sevelamer on Mineral and Lipid Abnormalities in Hemodialysis Patients
by: Hamida Fethi, et al.
Published: (2008-01-01)

Phosphate binders in chronic kidney disease: The positions of sevelamer
by: V V Fomin, et al.
Published: (2013-06-01)

Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients
by: Qian Zeng, et al.
Published: (2023-12-01)

The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and hs-CRP in Patients with Diabetic Nephropathy
by: Sosan Mohammadi Kebar, et al.
Published: (2018-04-01)

Sevelamer-associated ischemic colitis with perforation
by: Rachel Hudacko, et al.
Published: (2015-12-01)

Repurposing of sevelamer as a novel antidote against aluminum phosphide poisoning: An in vivo evaluation
by: Reza Heidari, et al.
Published: (2023-04-01)

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis
by: Yuki Tsuji, et al.
Published: (2020-06-01)

Evaluation of the safety and efficacy of transarterial sevelamer embolization in a rabbit liver cancer model: A challenge on the size rule for vascular occlusion
by: Hong Chen, et al.
Published: (2022-12-01)

Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study
by: Parminder Nain, et al.
Published: (2023-02-01)

Correction of hyperphosphatemia in hemodialysis patients: 12-month findings from a randomized study
by: I.O. Dudar, et al.
Published: (2022-08-01)

Pathology of Resin-Induced Gastrointestinal Damage: Report of 15 Cases and Review of Literature
by: Smiley Annie GEORGE, et al.
Published: (2019-09-01)

"Fish-scales" and graft nephrectomy: unexpected findings at an unusual site
by: Smiley Annie George, et al.
Published: (2017-10-01)

Crystal-Associated Colitis with Ulceration Leading to Hematochezia and Abdominal Pain
by: Meeta Desai, et al.
Published: (2016-06-01)

Phosphate binder in dialysis: a cross-sectional study of patients' adherence and pill burden
by: Brunelle Bruna Scavello Coelho Ferezin, et al.
Published: (2025-01-01)

Correction of hyperphosphatemia in a patient with end-stage chronic kidney disease and a complex case of anemia. A clinical case
by: Victor V. Fomin
Published: (2024-05-01)

Sevelamer hydrochloride and coronary artery calcification in chronic hemodialysis patients: a new mechanism of action
by: Bahaa Eldin Zayed, et al.
Published: (2015-01-01)

Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug–Bug Interaction?
by: Lu Dai, et al.
Published: (2020-05-01)

Case report: Sevelamer-associated colitis—a cause of pseudotumor formation with colon perforation and life-threatening bleeding
by: Margareta Fistrek Prlic, et al.
Published: (2023-04-01)

Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial
by: Kullaya Takkavatakarn, et al.
Published: (2021-09-01)

Drug Crystal-Related Gastrointestinal Complications Involve Crystal-Induced Release of Neutrophil and Monocyte Extracellular Traps
by: Tehyung Kim, et al.
Published: (2020-11-01)

The effects of sevelamer carbonate on blood glucose and inflammatory factors in patients with diabetic kidney disease; a controlled clinical trial
by: Shadi Botshekan, et al.
Published: (2021-05-01)

Canakinumab in addition to phosphate-binding and phosphaturia-inducing therapy were effective in achieving remission in a child with a large familial calcinotic tumour
by: Maria Ochoa, et al.
Published: (2023-12-01)

Effects of ground flaxseed supplementation on cardiovascular disease among hemodialysis patients at a goverment hospital, in Tehran, Iran
by: Soltani, Saman Khalatbari
Published: (2013)

Effects of ground flaxseed supplementation on cardiovascular disease among hemodialysis patients at a goverment hospital in Tehran, Iran
by: Soltani, Saman Khalatbari
Published: (2013)

Metabolic signature of protein energy wasting among Malaysian hemodialysis patients
by: Pauzi, Fatin Athirah
Published: (2020)

Brazilian Dialysis Survey 2022
by: Fabiana Baggio Nerbass, et al.
Published: (2023-12-01)

Hypertension in patients on dialysis: diagnosis, mechanisms, and management
by: Sérgio Gardano Elias Bucharles, et al.
Published: (2018-11-01)

COVID-19 incidence and outcomes among patients with kidney replacement therapy
by: Siribha Changsirikulchai, et al.
Published: (2023-09-01)

Comparative analysis of patients’ survival on hemodialysis vs. peritoneal dialysis and identification of factors associated with death
by: Carolina Aparecida de Almeida Vicentini, et al.
Published: (2022-05-01)

Factors associated with food choice values among older hemodialysis patients in selected dialysis centres in Selangor, Malaysia
by: Mohd Shahrin, Fatin Izzaty
Published: (2019)

Hemodialysis in Brazil: differences across geographic regions regarding demographics, laboratory parameters and drug prescription
by: Fabiana Baggio Nerbass, et al.
Published: (2023-06-01)

Clinical and microbiological effects of dialyzers reuse in hemodialysis patients
by: Isabella Carvalho Ribeiro, et al.
Published: (2019-01-01)

Caregiver Burden in Caregivers of RenalF Patients under Hemodialysis
by: Mitra Talebi, et al.
Published: (2016-06-01)

Brazilian Dialysis Survey 2020
by: Fabiana B Nerbass, et al.
Published: (2022-02-01)

Extracorporeal Treatment for Poisoning
by: Catarina Cardoso, et al.
Published: (2022-10-01)

Shared Decision Making for Choosing renAl Replacement Therapy in Chronic Kidney Disease Patients (SDM-ART trial): study protocol for randomized clinical trial
by: Jae Hyun Chang, et al.
Published: (2023-11-01)

Pseudoporfiria induzida pela diálise tratada com N-acetilcisteína oral Pseudoporphyria induced by dialysis treated with oral N-acetylcysteine
by: Marcelo Massaki Guiotoku, et al.
Published: (2011-04-01)